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0. Abstract 
The mitochondrial genome has recently become the focus of several high-impact 
next-generation sequencing studies investigating the effect of mutations in disease and 
assessing the efficacy of mitochondrial replacement therapies.  
However, these studies have failed to take into consideration the capture of recurring 
translocations of mitochondrial DNA to the nuclear genome, known as nuclear mitochondrial 
sequences (NUMTs), continuing to align sequence data to the revised Cambridge reference 
sequence alone.  
Here, using different mtDNA enrichment techniques and a variety of tissues, we 
demonstrate that NUMTs are present in sequence data and that, dependent upon downstream 
analysis, are at a level which affects variant calling. 
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1. Introduction  
 
Compared to nuclear DNA, mitochondrial DNA (mtDNA) is highly mutable1 and 
variants can be present in all (homoplasmy) or a proportion (heteroplasmy) of the molecules.2 
Mitochondrial DNA-like sequences in the nucleus (NUMTs) can interfere with the detection 
of heteroplasmy. For example, human chromosome 8 contains almost an entire mtDNA 
sequence inserted into the first intron of SDC2.3 This may yield misleading results in relation 
to heteroplasmy levels and highlights a need for greater rigor in the analysis of mtDNA 
sequence data, particularly as recent studies indicate that on average human individuals 
carries approximately 750 NUMTs, ~4 of which are unique.3,4 
With some exceptions, diseases caused by pathogenic mtDNA mutations are 
characterised by the co-existence of wildtype and mutated mtDNA. Crucially, the severity of 
disease symptoms associated with pathogenic mutations is determined by the relative levels 
of wild type and mutated mtDNA. Thus, accurate quantification of heteroplasmy, i.e. 
determination of allele frequencies at sites showing heteroplasmic variation, is critically 
important in the diagnosis, treatment and genetic counselling of mtDNA diseases.2 For 
example, for diseases such as myoclonic epilepsy and ragged-red fibres, in vitro studies have 
shown that the frequency of deleterious variant must exceed a threshold (typically 60-80%) 
before a biochemical deficit manifests, therefore accurate quantification is important for 
genetic diagnosis.5,6 Importantly, because of the way in which mtDNA variants segregate 
during development of the female germ line, women who are heteroplasmic for pathogenic 
mtDNA mutations, can produce eggs with widely varying mutation loads.7 This makes it very 
difficult to predict the risk of disease in their children.8 Thus, accurate quantification of 
heteroplasmy is therefore also essential for prenatal diagnosis and, more recently, is critical 
for reproductive technologies such, such as pre-implantation genetic diagnosis (PGD) and 
mitochondrial donation/replacement procedures such as pronuclear or spindle transfer.9 
In recent years several studies have utilised next generation sequencing (NGS) to 
investigate heteroplasmic mtDNA variation, assess the likely efficacy of mitochondrial 
replacement therapy in disease prevention,10,11 and investigate the effect of mtDNA variation 
on cell biology12 and in human disease.13-15 The materials analysed in such investigations 
typically range from single cells to tissue homogenates.13-15 In the vast majority of studies, 
one of three strategies are employed to isolate and enrich mtDNA for sequencing: several 
overlapping PCR amplicons (typically 100-2000 base-pairs long),16,17 long-range PCR 
(typically one or two overlapping large amplicons)11,14,15 or more recently, commercially 
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available mtDNA enrichment kits (typically relying on multiple displacement amplification 
producing series of overlapping sequence fragments).18,19 Earlier work amplifying the 
mtDNA genome as one large amplicon showed promise,20 unfortunately  this does not appear 
to have been widely adopted. Enriched mtDNA is sequenced and typically mapped to a 
mtDNA reference sequence such as the revised Cambridge Reference Sequence (rCRS, 
NM_012920.1), which is predominantly used to maintain variant position numbering 
consistency.10-19 
Given the importance of accurate heteroplasmy assessment for clinical and research 
purposes, we have systematically investigated the effect of the sample type (pooled cells and 
tissue homogenates), enrichment strategy and reference sequence on heteroplasmy 
assessment using the same bioinformatics pipeline. In addition, to gain insight into the impact 
of NUMTs on heteroplasmy assessment, we mapped mtDNA sequence data either to both the 
mtDNA reference sequence (rCRS or NM_012920.1) in isolation and to the combined 
nuclear (hg19) and mitochondrial (rCRS or NM_012920.1) genomes (hereafter referred to as 
simply hg19). Our findings indicate that the reference sequence choice has a significant effect 
on mtDNA variant calls, and that the results are also dependent on the isolation and 
enrichment steps used. 
 
2. Materials and Methods 
mtDNA was extracted and enriched for next-generation sequencing from a range of 
tissues using established methodology (Supplementary Materials). Next-generation 
sequencing was performed as per manufactures guidelines (Supplementary Materials). 
Downstream bioinformatic analysis was performed as described previously16,17,21 (and 
including Supplementary Materials). Raw data and analytical pipeline are available at: 
https://doi.org/10.5281/zenodo.1157051 
 
3. Results  
To test the effect of different isolation and enrichment steps, we compared 
heteroplasmy levels, i.e. the relative frequencies of the variants calls, using both rCRS-only 
and hg19 (which includes the rCRS reference) reference sequences (Figure 1). To highlight 
the effect on low level variation, the region representing relative variant frequencies below 
4% is expanded in Figure 2. Our data show that reference sequence choice has a significant 
effect on mtDNA variant calls, particularly those at low level, and that the results are also 
dependent on the isolation and enrichment steps used. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Using a two-amplicon long-range PCR approach to isolate and enrich mtDNA from 
either pooled cells or homogenate tissue, we found a high correlation in variant heteroplasmy 
when aligned to either rCRS alone or to the combined rCRS and hg19 reference sequences 
(R2=0.963 and R2=0.999 respectively, Figures 1a &1d, and Figures 2a and 2d); with the 
heteroplasmy of 96.3% (of 2486 variants) and 97.7% (of 260 variants) variants differing by 
less than 0.5% (Supplementary Table 1). 
We found that as amplicon size decreases the number of variants with discrepant 
frequencies increases (Supplementary Table 1 and, Figures 1 and 2). In the majority of cases, 
the frequency obtained using the rCRS-only as a reference is higher than that derived using 
hg19 (typically a ~2 to 50% increase). This appears to be influenced by both the initial 
enrichment procedure as well as the starting material. Notably, mtDNA enrichments from 
pooled cells (Figure 1b and 1c) compared with enrichment from tissue homogenate shows 
significantly higher numbers of variants with higher frequencies in analyses using alignment 
to the rCRS only. Using 9 amplicons and pooled cells as starting material, the frequency 
difference exceeded 0.5% for 5.5% of the variants while this was observed for only 0.2% of 
the variants when tissue homogenate was used (p<0.01). For a 180 amplicon strategy, the 
corresponding values were 3.0% and 0.4% (p<0.01, Supplementary Table 1). It is not clear 
what is causing this phenomenon, although it is likely that differences in starting material, 
which is known to affect PCR amplification efficiency and accuracy in low-template 
reactions is to blame.22 
The most extreme discrepancies we observed are putative variants that were only 
called when using one reference but not the other (i.e. rCRS-only versus hg19). In most 
cases, alignment to the rCRS-only detected heteroplasmic sites that could not be detected 
when aligning to hg19 (Supplementary Table 1). These variants are typically low level 
(Figure 2 and Supplementary Table 1), however some achieve frequencies above 20% and up 
to 100% (Figure 1b and c). Furthermore, the number of variants appears to be influenced by 
both starting material and amplification strategy, generally increasing in frequency as 
amplicon size decreases (Supplementary Table 1). Trimming the reads to remove primer 
sequences used in the 180-amplicon enrichment reduced the overall variant count 
(Supplementary Figure 1), however this does not diminish the number rCRS/hg19 
discrepancies (Supplementary Table 3). 
Analysis of sequence data generated from multiple displacement amplification (MDA, 
Figure 1g & 2g), showed very poor agreement between the results obtained using rCRS-only 
and hg19. By contrast, this was not seen when the same samples were amplified using a two-
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primer long range PCR strategy (Figure 1h & 2h). Similar to our other experiments, sequence 
alignment to the rCRS alone following MDA resulted in a high proportion (99% or 966 of all 
variants observed, =976) of variants present only when aligning to the rCRS, which were 
subsequently removed when the data was aligned to hg19. 
 
4. Discussion 
Our results show discrepancies between the variant calls obtained using different 
reference genomes. It is possible that including the nuclear genome in the reference excludes 
genuine mitochondrial variants, where the variation appears more similar to nuclear 
sequences than to the mitochondrial sequence included in the reference. However, the 
reduction in the number of discrepancies using larger amplicons indicates that a large 
proportion of the discrepancies reflect amplification on nuclear sequence. Given the 
stoichiometry between mitochondrial and single copy nuclear DNA this is likely to result in 
putative variants present at a low frequency. Their number would also be expected to increase 
when the complete mitochondrial genome is assessed using a set of short amplicons, since it 
is more difficult to avoid placing some of these within NUMTs and because of increased 
ambiguity when mapping shorter sequences. These considerations are consistent with our 
observations, where there is very little discrepancy in experiments using a two amplicon 
approach (see figure 1 and 2) as amplicon sizes are beyond the typical NUMT size (~100-
6000 bp).23 
Although differences between tissue type and enrichment strategy are known to affect 
the number of variants detected, in particular low frequency variants,24 our findings indicate 
that the choice of reference sequence seems to have a considerably large impact. The location 
of variants showing discrepancies in frequencies between analyses using different reference 
appears non-random, clustering around the D-loop and between 5,000 and 10,000 bp (Figure 
3), and appears independent of amplification strategy. However the association between 
variant position and primer binding site location did no achieve statistical significance.  
Thus, the most likely explanation for this is the co-amplification and subsequent 
sequencing of NUMTs. However we found no significant correlation between variant 
position and mtDNA positions which are covered by known NUMTs (Supplementary Table 
3). NUMT/mtDNA mean similarity is estimated as ~86% (standard deviation 4.1%, 
Supplementary Figure 2), however we found no correlation between percentage similarity 
and mtDNA variant positions. Taken together, this indicates that other factors, such as the 
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choice of starting material, also contribute to inaccuracy in the assessment of mtDNA 
heteroplasmy.  
 
5. Conclusion 
In conclusion, the accurate detection and quantification of mitochondrial 
heteroplasmy is dependent upon the initial enrichment strategy used, but more importantly on 
reference that is employed in downstream bioinformatic analysis. In particular, care should be 
taken interpreting heteroplasmic variants occurring within the D-loop and between 5,000 and 
10,000 base pairs of the mtDNA. If less specific enrichment strategies are used, i.e. small 
amplicons or MDA, then alignment should be compared to the combined nuclear and 
mitochondrial genomes (i.e. hg19). However, if a more specific enrichment strategy, i.e. 
multiple longer or one amplicon,20 is used then alignment to the rCRS in isolation may 
suffice. 
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Figure 1. Comparison of variant heteroplasmy level derived from alignment to either hg19 (x-axis) or 
the rCRS in isolation (y-axis) for different starting materials and enrichment procedures. Where, a) 
Pooled cells A; 2 amplicon LR-PCR, b) Pooled cells B; 9 amplicon PCR, c) Pooled cells C; 180 
amplicon PCR, d) Tissue Homogenate; 2 amplicon LR-PCR, e) Tissue homogenate; 9 amplicon PCR, 
f) Tissue homogenate; 180 amplicon PCR, g) CSF; MDA and h) CSF; 2 amplicon LR-PCR. The 
dotted line indicates the x/y reference line, i.e. where rCRS heteroplasmy=hg19 heteroplasmy. 
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Figure 2. Rescaled representation showing the effect of aligning to either hg19 (x-axis) or the rCRS 
in isolation (y-axis) for frequencies below 4%. Where, a) Pooled cells; 2 amplicon LR-PCR, b) 
Pooled cells; 9 amplicon PCR, c) Pooled cells; 180 amplicon PCR, d) Tissue Homogenate; 2 
amplicon LR-PCR, e) Tissue homogenate; 9 amplicon PCR, f) Tissue homogenate; 180 amplicon 
PCR, g) CSF; MDA and h) CSF; 2 amplicon LR-PCR. The dotted line indicates the x/y reference line, 
i.e. where rCRS heteroplasmy=hg19 heteroplasmy. 
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Figure 3. Frequency histogram showing the distribution of observed heteroplasmic variation relative 
to the position of known NUMT interference. Where a) Location of variants where the inferred 
frequency is higher when aligning to rCRS than to hg19), b) is the distribution of putative variants 
observed only when aligning to the rCRS (i.e. not observed when alignments hg19 are used ) and c) is 
the frequency of NUMTs coverage per mtDNA base pair. 
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Highlights: 
 Accurate next generation sequencing of mtDNA is affected by both enrichment and downstream 
bioinformatic analysis strategies. 
 NUMTs can affect heteroplasmy calling, but cannot wholly explain low-level sequencing 
artefacts.  
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